Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1628
    -0.0055 (-0.47%)
     
  • GBP/USD

    1.2392
    -0.0047 (-0.37%)
     
  • Bitcoin GBP

    51,746.30
    +570.46 (+1.11%)
     
  • CMC Crypto 200

    1,381.10
    +68.48 (+5.41%)
     
  • S&P 500

    4,987.04
    -24.08 (-0.48%)
     
  • DOW

    37,984.43
    +209.05 (+0.55%)
     
  • CRUDE OIL

    83.51
    +0.78 (+0.94%)
     
  • GOLD FUTURES

    2,414.40
    +16.40 (+0.68%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

BioLife Solutions (BLFS) Shares March Higher, Can It Continue?

Zacks.com featured highlights include: Lululemon, Sirius, Kohl's and Olympic Steel

As of late, it has definitely been a great time to be an investor in BioLife Solutions, Inc. BLFS. The stock has moved higher by 17.3% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider BLFS’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as BLFS has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

ADVERTISEMENT

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research